BiotechTube
Tepnel Pharma Services

Tepnel Pharma Services

Manchester, United Kingdom· Est.
tepnelpharmaservices.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $40M

Overview

Tepnel Pharma Services is a specialized pharmaceutical testing CRO founded in 1999 and headquartered in Manchester, UK, with its operational cGMP facility in Livingston, Scotland. The company offers a comprehensive suite of services including lot release testing, ICH method development and validation, raw material testing, and stability studies, operating under MHRA and FDA inspection. As a service provider, it generates revenue by supporting clients' regulatory submissions and quality control processes, positioning itself as a partner in the drug development lifecycle from pre-clinical through commercial stages.

DiagnosticsGenetics & Genomics

Technology Platform

Suite of regulatory-compliant analytical techniques (HPLC, GC, UPLC, Dissolution, ELISA) and methodologies following ICH, USP, EP, BP, and JP guidelines for pharmaceutical testing.

Funding History

2
Total raised:$40M
Series B$25M
Series A$15M

Opportunities

The growing trend of pharmaceutical outsourcing and increasing complexity of drug molecules (especially biologics and inhalation products) creates sustained demand for specialized testing services.
Expansion of service offerings or geographic reach through partnerships could drive further growth.

Risk Factors

Revenue is subject to cyclical pharmaceutical R&D spending and client project attrition.
Intense competition from larger global CROs and niche labs could pressure pricing and margins.
Maintaining stringent regulatory compliance (MHRA/FDA) is critical to avoid reputational damage or loss of accreditation.

Competitive Landscape

Tepnel operates in a highly competitive CRO market for analytical testing, competing against large global players (e.g., LabCorp, Charles River, Eurofins) and numerous specialized regional laboratories. Its differentiation lies in its specific expertise in complex dosage forms, regulatory approvals, and a client-partnering model based in Scotland.

More companies in Diagnostics & Precision Medicine →More companies in United Kingdom →